PubRank
Search
About
Xilin Zhao
Author PubWeight™ 42.31
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Quinolone-mediated bacterial death.
Antimicrob Agents Chemother
2007
2.94
2
Mutant selection window hypothesis updated.
Clin Infect Dis
2007
2.34
3
Contribution of oxidative damage to antimicrobial lethality.
Antimicrob Agents Chemother
2009
2.09
4
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
Mol Microbiol
2006
1.75
5
Quinolones: action and resistance updated.
Curr Top Med Chem
2009
1.73
6
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death.
J Antimicrob Chemother
2010
1.69
7
The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin.
Gastroenterology
2010
1.47
8
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.
Antimicrob Agents Chemother
2002
1.46
9
The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells.
Am J Physiol Gastrointest Liver Physiol
2011
1.41
10
The mutant selection window in rabbits infected with Staphylococcus aureus.
J Infect Dis
2006
1.25
11
Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.
Antimicrob Agents Chemother
2005
1.19
12
Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.
Antimicrob Agents Chemother
2012
1.13
13
Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
J Antimicrob Chemother
2003
1.10
14
Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
J Biol Chem
2014
1.08
15
Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus.
J Antimicrob Chemother
2007
1.03
16
Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
J Antimicrob Chemother
2005
1.02
17
Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus.
Antimicrob Agents Chemother
2011
1.02
18
A stem cell marker-expressing subset of enteroendocrine cells resides at the crypt base in the small intestine.
Am J Physiol Gastrointest Liver Physiol
2010
1.01
19
Multicolor combinatorial probe coding for real-time PCR.
PLoS One
2011
1.00
20
YihE kinase is a central regulator of programmed cell death in bacteria.
Cell Rep
2013
0.99
21
Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice.
Am J Physiol Gastrointest Liver Physiol
2012
0.99
22
Lateral flow immunoassay using europium chelate-loaded silica nanoparticles as labels.
Clin Chem
2008
0.97
23
Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.
Antimicrob Agents Chemother
2011
0.97
24
Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
Int J Antimicrob Agents
2006
0.95
25
Low correlation between MIC and mutant prevention concentration.
Antimicrob Agents Chemother
2006
0.95
26
Superoxide-mediated protection of Escherichia coli from antimicrobials.
Antimicrob Agents Chemother
2013
0.92
27
Escherichia coli genes that reduce the lethal effects of stress.
BMC Microbiol
2010
0.91
28
A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress.
PLoS One
2011
0.91
29
Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.
J Antimicrob Chemother
2003
0.91
30
The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function.
J Biol Chem
2003
0.89
31
Minimising moxifloxacin resistance with tuberculosis.
Lancet Infect Dis
2008
0.87
32
Clarification of MPC and the mutant selection window concept.
J Antimicrob Chemother
2003
0.81
33
Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?
Int J Antimicrob Agents
2004
0.80
34
Antimicrobial studies with the Pseudomonas aeruginosa two-allele library require caution.
Antimicrob Agents Chemother
2008
0.79
35
Mycoplasma pneumoniae infection is associated with subacute cough.
Eur Respir J
2013
0.78
36
Induction of mycobacterial resistance to quinolone class antimicrobials.
Antimicrob Agents Chemother
2012
0.77
37
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
N Engl J Med
2002
0.75
38
[Redintegration of articular surface with tibia type III Pilon fracture].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
2007
0.75